Women's Cancer Research Foundation

Directions Website Contact the organization

Women's Cancer Research Foundation The Mission of the Women’s Cancer Research Foundation is to improve cure rates for women with gynecological cancers. and the world.

Since 1985, the physicians from the Women’s Cancer Research Foundation (WCRF) have been pioneers in clinical research to improve cure rates for women with ovarian, uterine, endometrial, cervical, and other gynecological cancers. The WCRF is one of the most productive, efficient, and innovative clinical research groups in the U.S. WCRF designs, conducts, and publishes research on leading-edge medical advances. Because of the expense, workload, and regulations involved, only two percent of physicians do research nationwide and that number is dropping. Knowing this, and aware that research offers the best hope for women with gynecological cancers. WCRF Founder and President John Micha, M.D., and his physician partners created an innovative research model that exponentially increases efficiency and productivity. Our research has resulted in more effective treatment patterns and cure rates that are higher than the national averages. All of our physicians are passionate about research and we have created a system that makes it practical for them to do a great deal of research. Our WCRF team, led by a Ph.D., assists our physicians in writing the research protocols as well as the resulting papers. This approach results in publishing 12 to 15 research papers per year in prestigious journals such as Gynecologic Oncology, International Journal of Gynecologic Cancer and Obstetrics and Gynecology.WCRF is not only conducting and publishing original research, we are a clearinghouse for information about the latest advancements in treating gynecological cancers for physicians and patients.

Today, on Metastatic Breast Cancer Awareness Day, we recognize the women living with stage IV breast cancer—and the fami...
10/13/2026

Today, on Metastatic Breast Cancer Awareness Day, we recognize the women living with stage IV breast cancer—and the families, caregivers, clinicians, and researchers beside them.

Metastatic breast cancer is breast cancer that has spread beyond the breast. For the women living with it, awareness must mean more than visibility. It must mean continued research into treatments that extend life, improve quality of life, overcome treatment resistance, and create more options.

Progress has changed what living with metastatic breast cancer can look like, but there is still far more work to do. Every advance begins with research.

Please consider supporting the Women’s Cancer Research Foundation and the research that makes progress possible: https://www.womenscancerfoundation.com/support-wcrf

When people think about breast cancer, they often picture it affecting older women.The reality is more complex.While bre...
10/12/2026

When people think about breast cancer, they often picture it affecting older women.

The reality is more complex.

While breast cancer is still more common with age, diagnoses among younger women have been increasing by approximately 1.1% each year since 2012.

That doesn't mean younger women should live in fear. It does mean they should know their bodies, pay attention to changes, understand their family history, and have informed conversations with their healthcare provider about their personal risk.

Breast cancer doesn't always fit the expectations we have of it. The more we understand it, the better prepared we are to recognize it.

𝘛𝘩𝘦 𝘱𝘳𝘰𝘨𝘳𝘦𝘴𝘴 𝘸𝘦 𝘳𝘦𝘭𝘺 𝘰𝘯 𝘵𝘰𝘥𝘢𝘺 𝘦𝘹𝘪𝘴𝘵𝘴 𝘣𝘦𝘤𝘢𝘶𝘴𝘦 𝘴𝘰𝘮𝘦𝘰𝘯𝘦 𝘤𝘩𝘰𝘴𝘦 𝘵𝘰 𝘪𝘯𝘷𝘦𝘴𝘵 𝘪𝘯 𝘳𝘦𝘴𝘦𝘢𝘳𝘤𝘩 𝘺𝘦𝘢𝘳𝘴 𝘢𝘨𝘰. 𝘉𝘺 𝘴𝘶𝘱𝘱𝘰𝘳𝘵𝘪𝘯𝘨 𝘸𝘰𝘮𝘦𝘯'𝘴 𝘤𝘢𝘯𝘤𝘦𝘳 𝘳𝘦𝘴𝘦𝘢𝘳𝘤𝘩, 𝘺𝘰𝘶'𝘳𝘦 𝘩𝘦𝘭𝘱𝘪𝘯𝘨 𝘤𝘳𝘦𝘢𝘵𝘦 𝘣𝘦𝘵𝘵𝘦𝘳 𝘢𝘯𝘴𝘸𝘦𝘳𝘴, 𝘣𝘦𝘵𝘵𝘦𝘳 𝘵𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵𝘴, 𝘢𝘯𝘥 𝘮𝘰𝘳𝘦 𝘩𝘰𝘱𝘦 𝘧𝘰𝘳 𝘧𝘶𝘵𝘶𝘳𝘦 𝘨𝘦𝘯𝘦𝘳𝘢𝘵𝘪𝘰𝘯𝘴.

Menopause can change what feels “normal” in your body but new, persistent or unusual symptoms should never be automatica...
10/01/2026

Menopause can change what feels “normal” in your body but new, persistent or unusual symptoms should never be automatically dismissed as “just menopause.”

During National Menopause Awareness Month, the Women’s Cancer Research Foundation encourages women to pay attention to changes, ask questions and have honest conversations with their healthcare providers. Knowing your body matters at every age and through every stage.

Understanding medication risk requires more than identifying a possible association. It also requires examining how ofte...
09/29/2026

Understanding medication risk requires more than identifying a possible association. It also requires examining how often that outcome occurs, how length of use may affect risk, and what therapeutic benefits the medication provides.

A newly published review coauthored by 𝑾𝒐𝒎𝒆𝒏’𝒔 𝑪𝒂𝒏𝒄𝒆𝒓 𝑹𝒆𝒔𝒆𝒂𝒓𝒄𝒉 𝑭𝒐𝒖𝒏𝒅𝒂𝒕𝒊𝒐𝒏 𝑭𝒐𝒖𝒏𝒅𝒆𝒓 𝒂𝒏𝒅 𝑪𝒉𝒂𝒊𝒓𝒎𝒂𝒏 𝑱𝒐𝒉𝒏 𝑷. 𝑴𝒊𝒄𝒉𝒂, 𝑴.𝑫., and 𝗣𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁 𝗮𝗻𝗱 𝗦𝗲𝗻𝗶𝗼𝗿 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗙𝗲𝗹𝗹𝗼𝘄 𝗕𝗿𝗮𝗺 𝗛｡ 𝗚𝗼𝗹𝗱𝘀𝘁𝗲𝗶𝗻❟ 𝗣𝗵｡𝗗｡, examines available research on depot medroxyprogesterone acetate, commonly known as DMPA, and the risk of developing an intracranial meningioma.

The studies reviewed suggest that risk may increase with prolonged DMPA use. However, the actual number of meningioma cases associated with DMPA remains extremely low. The review emphasizes the need for additional research into the clinical risk–benefit relationship rather than drawing conclusions for every patient.

Patients who currently use DMPA or have concerns about previous use should speak with their healthcare provider before making any changes to their medication.

Read more about the findings and why understanding risk in context matters: https://www.womenscancerfoundation.com/post/new-wcrf-publication-examines-dmpa-use-and-meningioma-risk

This WCRF-funded publication reflects the kind of careful, continuing research your support helps make possible. If you would like to help sustain this work, please consider making a gift to the Women’s Cancer Research Foundation: https://www.womenscancerfoundation.com/support-wcrf

The strongest friendships aren’t built only on the easy conversations.Sometimes friendship sounds like:“Have you made th...
09/25/2026

The strongest friendships aren’t built only on the easy conversations.

Sometimes friendship sounds like:

“Have you made that appointment?”
“That change doesn’t sound normal for you.”
“Do you know your family’s cancer history?”
“Would you like me to go with you?”

During International Women’s Friendship Month, let’s remember that caring about someone means being willing to start the hard conversation. Even when it feels awkward.

A few uncomfortable minutes could encourage a friend to seek the care she needs.

Some days, a woman with ovarian cancer may need to talk about appointments, treatment, test results, or what she is afra...
09/23/2026

Some days, a woman with ovarian cancer may need to talk about appointments, treatment, test results, or what she is afraid of.

Other days, she may want to talk about work, television, celebrity gossip, or the ridiculous thing that happened in the group chat.

Follow her lead.

Cancer may change her schedule, her energy, and what she can do. It doesn't erase the rest of who she is. Continue inviting her into ordinary life, even when she can't always participate.

Send the meme.
Remember the appointment.
Check in without requiring a response.
Keep showing up after the first rush of messages and offers has faded.

You don't have to make everything better to help her feel less alone.

Read our latest article about supporting someone with ovarian cancer: https://www.womenscancerfoundation.com/post/support-someone-with-ovarian-cancer

If you would also like to support the research helping women live longer and experience a better quality of life, please consider a gift to the Women’s Cancer Research Foundation: https://www.womenscancerfoundation.com/support-wcrf

𝑸: 𝑪𝒂𝒏 𝒐𝒗𝒂𝒓𝒊𝒂𝒏 𝒄𝒂𝒏𝒄𝒆𝒓 𝒕𝒓𝒆𝒂𝒕𝒎𝒆𝒏𝒕 𝒂𝒇𝒇𝒆𝒄𝒕 𝒇𝒆𝒓𝒕𝒊𝒍𝒊𝒕𝒚?𝑨: 𝒀𝒆𝒔. Some ovarian cancer treatments can affect fertility, hormone pr...
09/21/2026

𝑸: 𝑪𝒂𝒏 𝒐𝒗𝒂𝒓𝒊𝒂𝒏 𝒄𝒂𝒏𝒄𝒆𝒓 𝒕𝒓𝒆𝒂𝒕𝒎𝒆𝒏𝒕 𝒂𝒇𝒇𝒆𝒄𝒕 𝒇𝒆𝒓𝒕𝒊𝒍𝒊𝒕𝒚?

𝑨: 𝒀𝒆𝒔. Some ovarian cancer treatments can affect fertility, hormone production, or when menopause begins.

For a younger woman, these effects may touch plans she has not yet made or decisions she never expected to face so soon. If having biological children now or in the future matters to her, she should tell her medical team as early as possible. When medically appropriate, fertility-preservation options may be discussed before treatment begins.

Her future priorities are not a distraction from her cancer care. They are part of the conversation.

Learn more in our latest article for younger women: https://www.womenscancerfoundation.com/post/ovarian-cancer-younger-women

Please share this information. It may help another woman know what to ask before treatment begins.

Women’s cancer research must consider cure rates, treatment outcomes, and quality of life. Your gift to the 𝑾𝒐𝒎𝒆𝒏'𝒔 𝑪𝒂𝒏𝒄𝒆𝒓 𝑹𝒆𝒔𝒆𝒂𝒓𝒄𝒉 𝑭𝒐𝒖𝒏𝒅𝒂𝒕𝒊𝒐𝒏 helps support research that considers the whole woman.

Give to women’s cancer research: https://www.womenscancerfoundation.com/support-wcrf

Your family’s cancer history matters long before middle age.When learning about ovarian cancer risk, ovarian cancer is n...
09/17/2026

Your family’s cancer history matters long before middle age.

When learning about ovarian cancer risk, ovarian cancer is not the only diagnosis worth asking about. Patterns of breast, uterine, colorectal, and certain other cancers, on either side of your family, may also provide important information.

If possible, find out which relatives had cancer, what type they had, how old they were when diagnosed, and whether anyone underwent genetic testing. You do not need to interpret that history yourself. Write down what you know and bring it to your healthcare provider.

Family history is information, not a prediction. But it can help you and your doctor have a more informed conversation about your individual risk.

Learn more in our latest article for younger women: https://www.womenscancerfoundation.com/post/ovarian-cancer-younger-women

Please share this article with a sister, daughter, friend, roommate, or coworker. These conversations should begin before someone has a reason to wish they had started sooner.

Continued research deepens our understanding of inherited cancer risk and helps move women’s cancer care forward. Please consider supporting that work with a gift to the Women’s Cancer Research Foundation.

Give to women’s cancer research: https://www.womenscancerfoundation.com/support-wcrf

When someone you care about is living with ovarian cancer, you may genuinely want to help but have no idea what would be...
09/16/2026

When someone you care about is living with ovarian cancer, you may genuinely want to help but have no idea what would be useful.

“Let me know if you need anything” is kind but it also leaves the person with cancer responsible for deciding what she needs, determining who to ask, and reaching out.

A specific offer may be easier to accept:

“I’m going to the grocery store Thursday. What can I bring you?”

“Would dinner on Tuesday or Friday be helpful?”

“I can drive you to your appointment, walk the dog, or pick up a prescription.”

Give her choices, respect her answer, and always make it easy to decline. Help should create breathing room, not another obligation she has to manage.

Sometimes the most helpful thing you can bring is not more information, it's lunch.

Read more about offering meaningful support to someone with ovarian cancer: https://www.womenscancerfoundation.com/post/support-someone-with-ovarian-cancer

Continued cancer research is another meaningful way to help. A gentle gift of any size supports the Women’s Cancer Research Foundation’s work to improve cure rates and quality of life for women with breast and gynecologic cancers: https://www.womenscancerfoundation.com/support-wcrf

Identifying a disparity is the beginning of a research question, not the end.A recent study found poorer overall surviva...
09/15/2026

Identifying a disparity is the beginning of a research question, not the end.

A recent study found poorer overall survival among Native Hawaiian/Pacific Islander and non-Hispanic Black women with epithelial ovarian cancer compared with non-Hispanic White women. The difference was especially pronounced among Native Hawaiian/Pacific Islander women with high-grade serous carcinoma.

The findings do not explain why these survival differences exist. They show where deeper investigation is needed—and why studying racial and ethnic groups with greater specificity matters.

𝑩𝒓𝒂𝒎 𝑮𝒐𝒍𝒅𝒔𝒕𝒆𝒊𝒏, 𝑷𝒉.𝑫., 𝑷𝒓𝒆𝒔𝒊𝒅𝒆𝒏𝒕 𝒂𝒏𝒅 𝑺𝒆𝒏𝒊𝒐𝒓 𝑪𝒍𝒊𝒏𝒊𝒄𝒂𝒍 𝑭𝒆𝒍𝒍𝒐𝒘 of the 𝑾𝒐𝒎𝒆𝒏'𝒔 𝑪𝒂𝒏𝒄𝒆𝒓 𝑹𝒆𝒔𝒆𝒂𝒓𝒄𝒉 𝑭𝒐𝒖𝒏𝒅𝒂𝒕𝒊𝒐𝒏, provides clinical context on what the study found and the questions that remain.

Read the full article: https://www.womenscancerfoundation.com/post/racial-ethnic-disparities-ovarian-cancer-survival

Address

Laguna Beach, CA

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Website

, ,

Alerts

Be the first to know and let us send you an email when Women's Cancer Research Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to Women's Cancer Research Foundation:

Shortcuts

Share

Category